Flagship Pioneering developed a platform for innovations in life sciences. Two billion dollars in investment and ten years later, Moderna and the covid-19 vaccine emerged.
August 3, 2021
Flagship Pioneering brought a new approach to innovation in life sciences that resulted in Moderna and a vaccine to fight off covid-19. At Signal 2021, Flagship founder Noubar Afeyan explained how it works: Unlike other investment companies, Flagship supports innovators in life sciences well before a business opportunity is clear, to help prove the viability of their potential product. And it does this at scale by providing a platform of technology tools useful across a range of applications in life sciences.
Learn more about Flagship, Moderna, and the race to develop the covid-19 vaccine: